Bayer and MD Anderson collaborate on novel targeted cancer treatments
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
X
Bayer and MD Anderson collaborate on novel targeted cancer treatments
https://pharmaphorum.com/news/bayer-md-anderson-novel-targeted-cancer-treatments/
